Home
Search results “Memorial sloan kettering papillary thyroid cancer”
Lymph Nodes in Thyroid Cancer -- Sloan-Kettering
 
04:47
Unlike in many other cancers, the spread of thyroid cancer to the lymph nodes has very little impact on survival in most patients, say thyroid cancer experts at Memorial Sloan-Kettering Cancer Center. Lymph nodes that look suspicious may be removed during thyroid surgery, but in most cases, this does not affect the outcome of treatment. For more information, please visit http://www.mskcc.org/thyroidcancer
Experts Discuss Thyroid Cancer Questions | Memorial Sloan Kettering
 
23:32
For more information on thyroid cancer, please visit http://www.mskcc.org/thyroidcancer Like us on Facebook: http://www.facebook.com/sloankettering Follow us on Twitter: http://twitter.com/sloan_kettering Physicians at Memorial Sloan Kettering Cancer Center answer a variety of questions such as risk factors for thyroid cancer, frequency of locally recurrent disease after initial treatment, the importance of experience in using and interpreting imaging data, side effects of radioactive iodine, clinical trials for thyroid cancers that do not respond to radioactive iodine, and the shift toward individualized treatment. {partial transcript} This is a very active area of investigation that has really seen the fruits of its labor over the past five to ten years. Even with more aggressive cancer, there are a lot of reasons to be optimistic? There is much more hope now than there was ten years ago. You talked a bit about before about folks of a certain age receiving radiation therapy for tumors that turned out to be benign. For instance, in children, the thymus gland was enlarged and it turned out to be normally enlarged. Unfortunately, we thought that was bad and a certain population of people ended up with thyroid cancer, secondary to their radiation therapy. Can we talk about risk factors for thyroid cancer and if there’s anything that we can do to avoid some of these risk factors? I’m not sure about how to avoid it, but regarding radiation, there is quite a bit of radiation from the diagnostic imaging in our general population….
Advances in Thyroid Cancer Treatment -- Sloan-Kettering
 
17:20
Memorial Sloan-Kettering Cancer Center specialists in endocrinology, surgery, and radiology discuss the latest approaches to diagnosing and treating thyroid cancer, and reducing the risk of recurrence. For more information, please visit http://www.mskcc.org/thyroidcancer.
Learn about our approach to thyroid cancer care.
 
02:44
Meet our thyroid cancer specialists and learn about our approach to care.
Management and Follow-up of High Risk Patients with Papillary Thyroid Cancer
 
34:20
Management and Follow-up of High Risk Patients with Papillary Thyroid Cancer -- R Michael Tuttle, MD Professor of Medicine, Endocrinology Service, Memorial Sloan Kettering Cancer Center, Cornell University, New York, NY, USA *** מוגש כשירות לציבור הגולשים והגולשות בלבד ואינו מהווה תחליף כלשהו לייעוץ רפואי אישי ופרטני ***
Views: 1965 Rambam Pro
Staging Thyroid Cancer and Residual Disease -- Sloan-Kettering
 
07:59
Diagnostic tools have become so sensitive that they can detect even the tiniest amount of thyroid cancer cells that remain after treatment. But just because doctors find some thyroid cancer cells does not always mean that additional treatment is necessary, say specialists at Memorial Sloan-Kettering Cancer Center, because they may not pose a significant threat to a patient's health. The side effects and costs of treatment must be considered carefully before treating these residual tumors. For more information, please visit http://www.mskcc.org/thyroidcancer
Diagnosing Thyroid Cancer -- Sloan-Kettering
 
03:28
Radiologist Lucy Hann of Memorial Sloan-Kettering Cancer Center explains how ultrasound is used to determine whether a thyroid tumor is benign (noncancerous) or malignant (cancerous). Features such as the amount of calcification or fluid a tumor contains can help doctors determine whether a patient requires a biopsy or surgery. For more information, please visit http://www.mskcc.org/thyroidcancer
Thyroid Cancer Survivor: Lani Mills
 
00:28
Diagnosed with papillary thyroid cancer at 37. Cured with surgery and radioiodine therapy Read more here:http://ow.ly/AXLuP SHARE AND SUPPORT http://www.camerasovercancer.org/ - created at http://animoto.com
The basics of thyroid cancer - Penn State Hershey Cancer Institute
 
04:55
David Goldenberg, M.D., discusses the various types of thyroid cancer, how they're detected, how they're treated -- and how the prognosis can vary depending on the type. Dr. Goldenberg is director of head and neck surgery at Penn State Hershey Medical Center.
Views: 6648 PennStateHershey
Case Study: Treating Papillary Thyroid Cancer
 
05:12
Marcia S. Brose, MD, PhD, presents a case study focused on a women diagnosed with papillary thyroid cancer at age 35 who went on to receive systemic therapy. For more from this discussion, visit http://www.onclive.com/peer-exchange/thyroid-cancer
Views: 2571 OncLiveTV
Thyroid Cancer Patient Stories
 
01:45
Butterfly Thyroid Cancer Trust is the first charity in the UK to be dedicated solely to the support of patients with thyroid cancer. This short clip provides a brief insight into the experiences of Papillary Thyroid Carcinoma survivors, and is part of a forthcoming thyroid cancer film to be distributed free to all new thyroid cancer patients in the UK. http://www.butterfly.org.uk http://www.euanpreston.com
Views: 10972 ButterflyTCT
Thyroid Cancer: Nodules and Diagnosis, including Recurrence. Dr. Haugen. ThyCa Conference
 
01:00:44
Determining a Thyroid Cancer Diagnosis and Diagnosing a Recurrence: Evaluating Nodules. Bryan R. Haugen, M.D., Endocrinologist
Dr. Sherman on Pazopanib in Anaplastic Thyroid Cancer
 
02:20
Eric J. Sherman, MD, Head and Neck Oncology Service, Memorial Sloan-Kettering Cancer Center, discusses the treatment of anaplastic thyroid cancer with intensity-modulated radiation therapy (IMRT), paclitaxel, and pazopanib. For more on head and neck cancer: http://www.onclive.com/specialty/head-and-neck
Views: 746 OncLiveTV
My experience with thyroid cancer
 
06:36
This video explains my thoughts about thyroid cancer. It also explains my experience with my surgeries.
Views: 51351 ooshkey
12-2 - Jatin P Shah - Treatment for Differentiated Cancer (Part 2)
 
14:51
1 Treatment for Differentiated Thyroid Gland Cancer 2 Thyroid Cancer: Issues 3 Incidence and Mortality US 4 Differentiated Cancer of the Thyroid Gland 5 Pathology 6 Prognosis 7 Exploiting Biology for Management 8 Prognosis in Thyroid Cancer 9 Genetic Progression in Papillary Cancers 10 Clinical parameters in management 11 Differentiated Cancer of the Thyroid Gland 12 Thyroid Cancer: Source of Data 13 Papillary Cancer: Surgical treatment 14 Follicular Cancer: Surgical treatment 15 Papillary Relative Survival 16 Survival at 5 Years vs Type of Surgical Treatment 17 Prognosis: Parameters to rely on 18 Prognostic Factors 19 Prognostic factors: 20-Year Survival 20 Risk stratification of patients 21 Selection of Therapy 22 Lobectomy vs Total Thyroidectomy 23 Thyroid Carcinoma with Extrathyroid Extension 24 Surgery for Extrathyroid Extension 25 Invasion of Recurrent Laryngeal Nerve 26 Invasion of the Trachea 27 Video: Total Thyroidectomy, Trachea Resection 28 Case Examples 29 Extrathyroid Extension: Esophagus 30 Case Examples 31 Patterns of Neck Metastases 32 Central Compartment Node Dissection 33 Modified Radical ND, Case Examples 34 Differentiated Cancer of the Thyroid: Follow up 35 Low Risk Thyroid Cancer: Data Mayo Clinic 36 Problems with the Current Follow Up Regimen 37 Genetic Progression Model 38 Molecular Factors in Thyroid Cancer 39 Summary
Views: 3694 StatementsCancer
Dr. Tuttle on Augmenting Pre-Operative Risk of Recurrence Stratification in DTC
 
01:38
R. Michael Tuttle, MD, Memorial Sloan Kettering Cancer Center, discusses a study that looked at augmenting pre-Operative risk of recurrence stratification in differentiated thyroid carcinoma. For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
Views: 348 Targeted Oncology
Lymph Nodes in Thyroid Cancer
 
04:47
Experts from MSKCC say that removing suspicious lymph nodes during thyroid cancer surgery may not affect treatment outcomes for most patients.
Biopsies and Novel Therapies for Thyroid Cancer -- Sloan-Kettering
 
04:31
Radiologist Lucy Hann describes a quick and relatively painless procedure called fine-needle biopsy, which is used to extract thyroid tumor cells for analysis under a microscope. Endocrinologist Michael Tuttle describes new drugs currently in clinical trials that have improved the ability to treat patients with aggressive tumors that are resistant to radioactive iodine therapy. For more information, please visit http://www.mskcc.org/thyroidcancer
Papillary Thyroid Cancer - Post3
 
01:51
My Journey through diagnosis, treatment and comeback :)
Views: 883 MyCancerJournal
Panel Discussion: Surgical Treatment for Papillary Thyroid Cancer Moderator: Ziv Gil, MD, PhD (ENT)
 
21:00
Panel Discussion: Surgical Treatment for Papillary Thyroid Cancer Moderator: Ziv Gil, MD, PhD Chairman, Department of Otolaryngology, Rambam HCC, Haifa -- Gideon Bachar, MD Department of Otolaryngology, Rabin Medical Center, Petah Tikva -- Diana Gaitini, MD Director, Ultrasound Unit, Department of Medical Imaging, Rambam HCC, Haifa -- Haitam Nasrallah, MD Institute of Oncology, Rambam HCC, Haifa -- Moshe Shabtai, MD Vice Chairman, Department of Surgery, Head Endocrine Surgery Service, The Chaim Sheba Medical Center, Tel-Hashomer -- R Michael Tuttle, MD Professor of Medicine, Endocrinology Service, Memorial Sloan Kettering Cancer Center, Cornell University, New York, NY, USA *** מוגש כשירות לציבור הגולשים והגולשות בלבד ואינו מהווה תחליף כלשהו לייעוץ רפואי אישי ופרטני ***
Views: 1175 Rambam Pro
What does Thyroid Cancer look like?
 
00:16
Here is a short video showing my malignant tumour (Papillary Thyroid Carcinoma) before the surgeons cut it out. The tumour was 6 cm in size and as you will see in the video, not really visible until I swallowed. I am publishing the video to raise awareness of Thyroid Cancer, in the hope that other people with similar lumps on their neck, will see their doctor before it reaches this size. You can see the tumour twice in this video - once each from two different angles. There is a short delay between the two, as I found it difficult to swallow at the time. PLEASE TAKE NOTE: Having a lump similar to this DOES NOT mean you have Cancer. My mother also had a lump the same and hers was NOT Cancerous. The point is... DON'T PANIC, BUT DON'T IGNORE IT. See a doctor and find out.
Views: 9479 Emma MacDonald
Staging Thyroid Cancer and Residual Disease
 
07:59
MSKCC thyroid cancer experts say that additional treatment may not be needed for residual tumors that do not pose a threat to a patient’s health.
papillary thyroid cancer - post 1
 
06:45
My journey through papillary thyroid cancer diagnosis, treatment and recovery to help others in similar situations
Views: 4182 MyCancerJournal
Mechanism-based Therapies for Advanced Thyroid Cancers
 
51:50
A Division of Endocrinology, Diabetes and Bone Diseases Grand Rounds presented by James A. Fagin, MD, Memorial Sloan Kettering Cancer Center
Thyroid Cancer | Dr. Tony Talebi Discusses the Treatment of Papillary Thyroid Cancer
 
50:20
Dr Tony Talebi discusses the treatment of papillary thyroid cancer with Dr. Kim, Assistant professor of medicine at University of Miami and director of thyroid diseases. Dr Talebi is the owner of Miami Hematology and Oncology Associates.
Views: 8857 Tony Talebi
Endoscopic total thyroidectomy with node dissection for papillary thyroid cancer
 
08:21
This video demonstrates the technique of total thyroid excision with lymph node removal for papillary thyroid cancer.
Views: 49250 MountSinaiMEMIS
Diagnosing Thyroid Cancer
 
03:28
Radiologist Lucy Hann describes the role of ultrasound in determining whether a thyroid tumor is cancerous or noncancerous.
Julie Nance - Thyroid Cancer Survivor
 
03:27
Thyroid cancer survivor Julie Nance shares the story of her treatment at Sylvester Comprehensive Cancer Center, part of UHealth -- University of Miami Health System. Carla was treated by David Arnold, M.D., associate professor at the Miller School of Medicine.
12-3 - Jatin P Shah -  Treatment for Differentiated Cancer (Part 3)
 
10:29
1 Treatment for Differentiated Thyroid Gland Cancer 2 Thyroid Cancer: Issues 3 Incidence and Mortality US 4 Differentiated Cancer of the Thyroid Gland 5 Pathology 6 Prognosis 7 Exploiting Biology for Management 8 Prognosis in Thyroid Cancer 9 Genetic Progression in Papillary Cancers 10 Clinical parameters in management 11 Differentiated Cancer of the Thyroid Gland 12 Thyroid Cancer: Source of Data 13 Papillary Cancer: Surgical treatment 14 Follicular Cancer: Surgical treatment 15 Papillary Relative Survival 16 Survival at 5 Years vs Type of Surgical Treatment 17 Prognosis: Parameters to rely on 18 Prognostic Factors 19 Prognostic factors: 20-Year Survival 20 Risk stratification of patients 21 Selection of Therapy 22 Lobectomy vs Total Thyroidectomy 23 Thyroid Carcinoma with Extrathyroid Extension 24 Surgery for Extrathyroid Extension 25 Invasion of Recurrent Laryngeal Nerve 26 Invasion of the Trachea 27 Video: Total Thyroidectomy, Trachea Resection 28 Case Examples 29 Extrathyroid Extension: Esophagus 30 Case Examples 31 Patterns of Neck Metastases 32 Central Compartment Node Dissection 33 Modified Radical ND, Case Examples 34 Differentiated Cancer of the Thyroid: Follow up 35 Low Risk Thyroid Cancer: Data Mayo Clinic 36 Problems with the Current Follow Up Regimen 37 Genetic Progression Model 38 Molecular Factors in Thyroid Cancer 39 Summary
Views: 12525 StatementsCancer
Dr. Sherman on Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer
 
01:30
Eric J. Sherman, MD, Head and Neck Oncology Service, Memorial Sloan-Kettering Cancer Center, discusses a pilot study of selumetinib-enhanced radioiodine uptake in advanced thyroid cancer. More on head and neck cancer: http://www.onclive.com/specialty/head-and-neck
Views: 234 OncLiveTV
Living With Thyroid Cancer: After Surgery Follow-up Care
 
04:02
Surgeons, doctors and professionals discuss the many aspects of thyroid surgery aftercare, including who is involved (it's not just the surgeons!), what to expect as far as after-surgery symptoms to watch for and activities to avoid, and their own personal theories on aftercare best practices. Featuring: David Myssiorek, MD (New York University School of Medicine), R. Michael Tuttle, MD (Memorial Sloan Kettering), Joshua Klopper, MD (University of Colorado).
Dr. R. Michael Tuttle on New Horizons for Radioactive Iodine Treatment
 
01:37
R. Michael Tuttle, MD, professor of Medicine, Memorial Sloan Kettering Cancer Center talks about the new horizons for radioactive iodine treatment in thyroid cancer. He says some new treatments, like the MAP kinase inhibitor and BRAF inhibitor, block pathways that would allow a cancerous thyroid tumor to concentrate radio iodine. For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
Views: 307 Targeted Oncology
Anaplastic Thyroid Cancer Sosa and Tuttle 07292011
 
01:03:42
Published on Jul 27, 2014 Anaplastic Thyroid Cancer Recorded July 29, 2011 Speakers: Julie Ann Sosa, M.D., M.A. and R. Michael Tuttle, M.D. Julie Ann Sosa, M.D., M.A., is an Endocrine and Oncologic Surgeon and Associate Professor of Surgery at Yale University School of Medicine, New Haven, Connecticut. She is principal investigator or co-principal investigator of studies of new drug treatments for differentiated thyroid cancer (papillary/follicular), medullary thyroid cancer, and anaplastic thyroid cancer. Following undergraduate education at Princeton University, she received a master's degree in Human Sciences at the University of Oxford in the United Kingdom and her medical degree from Johns Hopkins University School of Medicine, Baltimore, Maryland. She received postgraduate training at Johns Hopkins Hospital in Baltimore, Maryland, as well as John Radcliffe and Churchill Hospitals, Oxford, England. She is a frequent invited lecturer and course leader/instructor for professional audiences. She is a member of ThyCa”s Medical Advisory Council. R. Michael Tuttle, M.D. is an endocrinologist at Memorial Sloan-Kettering Cancer Center, New York, New York. He is also Professor of Medicine at the Joan and Sanford I. Weill Medical College of Cornell University in New York, NY. He is an active clinician and researcher specializing in the management of advanced thyroid cancer. He travels extensively both within the US and abroad lecturing on the difficult management issues in thyroid cancer. His research projects in radiation-induced thyroid cancer have taken him from Kwajalein Atoll in the Marshall Islands to the Hanford Nuclear power-plant in Washington State to regions in Russia that were exposed to fallout from the Chernobyl accident. He serves on the American Thyroid Association committee that produced the current guidelines for the management of benign and malignant thyroid nodules. He also chaired the National Comprehensive Cancer Network Thyroid Cancer Panel, and served on the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug, and as a consultant. He is a member of ThyCa”s Medical Advisory Council. Moderator: Jan Halzel, Pharm.D. Jan Halzel, Pharm.D. works in drug safety and clinical data management in the pharmaceutical industry. She is a co-moderator of ThyCa's Medullary Thyroid Cancer E-mail Support Group and is involved in developing the Medullary Thyroid Cancer content on ThyCa's web site. She also represents ThyCa at medical association meetings. She earned her bachelor's degree in pharmacy at the University of Rhode Island and her doctoral degree at the University of Colorado Health Sciences Center. She is a member of ThyCa's Medical Advisory Council.
Papillary Thyroid Cancer - Post 2
 
06:42
My journey through papillary thyroid cancer diagnosis, treatment and recovery to help others in similar situations. This is a post surgery update Quick notes: Day 1- 5 hour plus surgery Day 2- body numb, Meds for pain, throat sore, small memory loss, depleted calcium, Chyle leaks, diet mess up Day 3- Nauseau, intense pain, more calcium supplements, chyle leaks continue, walking around Day 4-pain random, calcium up, leak down Day 5 - pain controlled, calcium up, leak down Day 6 - ready to go home, one more day of observation Day 7- discharged with drain tubes. Light pain in back Day 8 - Leak fully down, intense muscular skeletal spams in back - muscle relaxants Day 9 - all pain down, minor leak Day 10 - drain tubes out. Minor victories like shaving properly, holding kid :) Meds - Muscle relaxants, Pain, Calcium 3 kinds, Thyroid Hormone How am I getting through this- Amazing love from my Wife; Pretty smiles and kisses from my 7 month old; Physical presence and care from Andy, Jeanie, Alison; support from quality colleagues / bosses; a lot of well wishers in my life. Humbled.
Views: 3547 MyCancerJournal
Living with Thyroid Cancer: Lori's Story
 
05:47
Lori has been living with thyroid cancer since 2008. In this video she talks about the things that have helped her through her diagnosis along with the many treatments she has undergone. This is an inspiring story of a person's struggle to come to terms with cancer. http://www.streamingwell.com/thyroid-cancer-loris-story-video.html Streaming Well is a healthcare focused, award-winning video production company which operates in the US and Europe. Find us at: http://www.streamingwell.com Subscribe to Streaming Well: http://www.youtube.com/subscription_center?add_user=StreamingWell Like us on: http://www.facebook.com/StreamingWell Follow us on: http://www.twitter.com/StreamingWell Follow us on: http://www.instagram.com/streamingwell Follow us on: http://pinterest.com/StreamingWell/
Views: 21192 streamingwell
Papillary Thyroid Cancer | Symptoms, Treatments, and Prognosis for Papillary Thyroid Cancer
 
01:18
Papillary Thyroid Cancer | Symptoms, Treatments, and Prognosis for Papillary Thyroid Carcinoma, all about Papillary Thyroid Cancer. VISIT: ►►► http://Papillary-ThyroidCancer.com ◄◄◄ http://www.youtube.com/watch?v=eVM4Vs47IW0 Papillary thyroid cancer (also sometimes called papillary thyroid carcinoma) is the most common type of thyroid cancer. You may have even heard your doctor talk about metastatic papillary thyroid cancer ("metastatic" means that it has spread beyond your thyroid gland). This article will focus on papillary thyroid cancer basics, including papillary thyroid cancer symptoms, treatments, and prognosis Papillary thyroid carcinoma is the most common thyroid cancer. About 80% of all thyroid cancers cases are papillary thyroid cancer.1 What are some papillary thyroid cancer signs and symptoms? Papillary carcinoma typically arises as an irregular, solid or cystic mass that comes from otherwise normal thyroid tissue. This cancer has a high cure rate with 10-year survival rates for all patients with papillary thyroid cancer estimated at 80% to 90%. Cervical metastasis (spread to lymph nodes in the neck) are present in 50% of small papillary carcinomas and in more than 75% of the larger papillary thyroid carcinomas. The presence of lymph node metastasis in these cervical areas causes a higher recurrence rate but not a higher mortality rate. Distant metastasis is uncommon, but lung and bone are the most common sites if the papillary carcinoma does spread. Tumors that invade or extend beyond the thyroid capsule have a much worse prognosis because of a high local recurrence rate. But what do doctors look for to diagnose papillary thyroid cancer? Characteristics of Papillary Thyroid Cancer Peak onset ages are 30 to 50 years old. Papillary thyroid cancer is more common in females than in males by a 3:1 ratio. The prognosis directly related to tumor size. (Less than 1.5 cm [1/2 inch] is a good prognosis.) This cancer accounts for 85% of thyroid cancers due to radiation exposure. In more than 50% of cases, it spreads to lymph nodes of the neck. Distant spread (to lungs or bones) is uncommon. The overall cure rate is very high (near 100% for small lesions in young patients). Although survival following papillary thyroid cancer (PTC) is high, a small but significant number of recurrences and deaths occur decades after diagnosis, a long-term study has found. The 3 most commonly cited studies on PTC have median follow-up times of 11, 15, and 15.7 years. In contrast, the new research reports on a median of 27 years of follow-up in a cohort of 269 PTC patients, said Raymon H. Grogan, MD, assistant professor of surgery and director of the endocrine surgery research program at the University of Chicago Medicine, Illinois. He presented the findings this week here at the American Association of Endocrine Surgeons 2013 Annual Meeting. Papillary thyroid cancer (as is the case with follicular thyroid cancer) typically occurs in the middle aged with a peak incidence in the 3rd and 4th decades. It is more common in women with a F:M ratio of 1:1.6 - 3:1 2. Papillary thyroid cancer, which is the most common type of thyroid cancer, makes up about 80% of all cases of thyroid cancer. It is one of the fastest growing cancer types with over 20,000 new cases a year. In fact, it is the 8th most common cancer among women overall and the most common cancer in women younger than 25. Most Patients Survive Papillary Thyroid Cancer Regardless of Treatment According to a study reported on in the May, 2010 issue of the Archives of Otolaryngology-Head & Neck Surgery, papillary thyroid cancer that has not spread outside the thyroid gland has a generally favorable outcome for patients, whether or not they receive treatment within a year of diagnosis. According to the study author, "...nearly every thyroid gland might be found to have a cancer if examined closely enough. The advent of ultrasonography and fine-needle aspiration biopsy has allowed many previously undetected cancers to be identified, changing the epidemiology of the disease. Over the past 30 years, the detected incidence of thyroid cancer has increased three-fold, the entire increase attributable to papillary thyroid cancer and 87% of the increase attributable to tumors measuring less than 2 centimeters." Although survival following papillary thyroid cancer (PTC) is high, a small but significant number of recurrences and deaths occur decades after diagnosis, a long-term study has found. "Papillary thyroid cancer in general has a very good prognosis... Also, papillary thyroid cancer rates have been rising steadily for several decades worldwide. The combination of these 2 factors means that more and more people will be living with [the diagnosis] for several decades. This is why we think our study is important," Dr. Grogan told Medscape Medical News. Papillary Thyroid Cancer http://www.youtube.com/PapillaryThyroidCanc . .
Living With Thyroid cancer
 
02:58
Thyroid cancer affects the thyroid gland in the body. Learn more about Thyroid cancer and what it is like to live with it in this video.
Views: 7674 LIVESTRONG.COM
Thyroid Cancer: NOT the Good Cancer
 
04:47
Thyroid Cancer is NOT the "good cancer." Compiled by Nikki Ferraro, thyroid cancer survivor and founder of Bite Me Cancer www.bitemecancer.org
Views: 36255 Bite Me Cancer
Living with Thyroid Cancer
 
03:03
Thyroid cancer develops in the thyroid gland at the base of the neck. Find out what it is like to live with thyroid cancer from a patient in this disease condition video.
Views: 14997 LIVESTRONG.COM
Recurrence of a papillary carcinoma of the thyroid. Lymph nodes in the neck - case 14
 
00:41
Complete case history on http://www.thyrosite.com/thyroid/1277/index.htm
Views: 503 Tamas Solymosi
Thyroid Cancer: Biomarkers and Lessons from The Cancer Genome Atlas. Dr. Giordano. ThyCa Conference
 
01:11:25
Biomarkers in Thyroid Cancer: Lessons From The Cancer Genome Atlas (TCGA). Thomas J. Giordano, M.D., Ph.D., Pathologist
Thyroid Cancer: Lymph Node Evaluation & Mapping, Pre- & Post-Operative. Dr. Patel. ThyCa Conference
 
01:04:35
A Discussion of Lymph Node Evaluation in the Setting of Thyroid Cancer: Pre- and Post-Operative Nodal Mapping and Assessment. Nayana Patel, M.D., Radiologist
Living with Advanced Thyroid Cancer: Christine's Story (Excerpt)
 
05:11
Living with Advanced Thyroid Cancer: Christine's Story (Excerpt)
Views: 8034 ButterflyTCT
Mayo Clinic Study:  High-Tech Imaging Contributing to Overdiagnosis of Low-Risk Thyroid Cancers
 
03:54
An increasing gap between the incidence of thyroid cancer and deaths from the disease suggests that low-risk cancers are being overdiagnosed and overtreated. The study from the Mayo Clinic Center for the Science of Health Care Delivery is in the current issue of the BMJ. Lead author Juan Brito, M.B.B.S., an endocrine fellow and health care delivery scholar at Mayo Clinic, says, "High-tech imaging technologies such as ultrasound, CT and MRI can detect very small thyroid nodules many of which are slow growing papillary thyroid cancers.
Views: 2340 Mayo Clinic
Differentiated Thyroid Cancer McIver 08022011
 
01:06:59
Published on Jul 25, 2014 Papillary/Follicular Thyroid Cancer – A Primer Recorded August 2, 2011 Speaker: Bryan McIver, M.B., Ph.D. Bryan McIver, M.B., Ph.D., F.R.C.P., Endocrinologist, is with the Thyroid Group within the Division of Endocrinology at Mayo Clinic in Rochester, Minnesota; this group has more than 40 full-time endocrine specialists. As a consultant in endocrinology, metabolism and nutrition, he has extensive experience treating patients with diseases of the thyroid, specifically those faced with aggressive cancers such as anaplastic thyroid cancer and other advanced thyroid cancers. He also runs a research lab, working on thyroid cancer genetics and on new treatments for patients with thyroid cancer. Dr. McIver has received numerous awards and honors, including the Endocrine Society Mentor Award for Outstanding Research. He graduated Summa Cum Laude in Medical Sciences from the University of Edinburgh in Scotland, received his Ph.D. in Physiology and Biophysics from the University of Vermont; and his M.B. Ch.B. Faculty of Medicine at the University of Edinburgh. He is a member of the American Thyroid Association’s Thyroid Cancer Guidelines Development Group. He is a member of ThyCa's Medical Advisory Council. Moderator: Jan Halzel, Pharm.D. Jan Halzel, Pharm.D. works in drug safety and clinical data management in the pharmaceutical industry. She is a co-moderator of ThyCa's Medullary Thyroid Cancer E-mail Support Group and is involved in developing the Medullary Thyroid Cancer content on ThyCa's web site. She also represents ThyCa at medical association meetings. She earned her bachelor's degree in pharmacy at the University of Rhode Island and her doctoral degree at the University of Colorado Health Sciences Center. She is a member of ThyCa's Medical Advisory Council.
Panel Discussion: Treatment and Follow-up of Low Risk Patients
 
24:19
Panel Discussion: Treatment and Follow-up of Low Risk Patients Moderator: Ziv Gil, MD, PhD Department of Otolaryngology Head and Neck Surgery, Rambam HCC -- Rahamim Ben Yosef, MD Director, Radiation Unit, Institute of Oncology, Rambam HCC, Haifa -- Michael Krausz MD Chief of Endocrine Surgery Service, Department of Surgery, Hillel Yaffe Medical Center, Hadera -- R Michael Tuttle, MD Professor of Medicine, Endocrinology Service, Memorial Sloan Kettering Cancer Center, Cornell University, New York, NY, USA -- Tzila Zwas, MD Department of Nuclear Medicine, Hasharon Hospital, Rabin Medical Center, Petah Tikva
Views: 390 Rambam Pro
Living With Thyroid Cancer: When Radioactive Iodine Fails
 
05:01
When people stop responding to radioactive iodine, they are what is called refractory. Treatment after this point is aggressive and there is often a period of watchful waiting before the next step in treatment. These thyroid cancer patients need new treatment solutions. Right now there are two angiogenic agents called Nexavar and Lenvima. They increase the time it takes for metastatic thyroid cancer to grow. These agents and many clinical trials on the horizon, kinase inhibitors and immunotherapy. There is finally hope for these patients.